Literature DB >> 19705500

Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi-detector row computed tomography.

Ling Tan1, Ya-E Zhao, Deng-Bin Wang, Qing-Bing Wang, Jing Hu, Ke-Min Chen, Xia-Xing Deng.   

Abstract

AIM: To retrospectively evaluate the imaging features of pancreatic intraductal papillary mucinous neoplasms (IPMNs) in multi-detector row computed tomography (MDCT).
METHODS: A total of 20 patients with pathologically-confirmed intraductal papillary mucinous neoplasms (IPMNs) were included in this study. Axial MDCT images combined with CT angiography (CTA) and multiplanar volume reformations (MPVR) or curved reformations (CR) were preoperatively acquired. Two radiologists (Tan L and Wang DB) reviewed all the images in consensus using an interactive picture archiving and communication system. The disputes in readings were resolved through consultation with a third experienced radiologist (Chen KM). Finally, the findings and diagnoses were compared with the pathologic results.
RESULTS: The pathological study revealed 12 malignant IPMNs and eight benign IPMNs. The diameters of the cystic lesions and main pancreatic ducts (MPDs) were significantly larger in malignant IPMNs compared with those of the benign IPMNs (P < 0.05). The combined-type IPMNs had a higher rate of malignancy than the other two types of IPMNs (P < 0.05). Tumors with mural nodules and thick septa had a significantly higher incidence of malignancy than tumors without these features (P < 0.05). Communication of side-branch IPMNs with the MPD was present in nine cases at pathologic examination. Seven of them were identified from CTA and MPVR or CR images. From comparison with the pathological diagnosis, the sensitivity, specificity, and accuracy of MDCT in characterizing the malignancy of IPMN of the pancreas were determined to be 100%, 87.5% and 95%, respectively.
CONCLUSION: MDCT with CTA and MPVR or CR techniques can elucidate the imaging features of IPMNs and help predict the malignancy of these tumors.

Entities:  

Mesh:

Year:  2009        PMID: 19705500      PMCID: PMC2731955          DOI: 10.3748/wjg.15.4037

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases.

Authors:  Pierre Bernard; Jean-Yves Scoazec; Madeleine Joubert; Xavier Kahn; Joël Le Borgne; Françoise Berger; Christian Partensky
Journal:  Arch Surg       Date:  2002-11

2.  Surgical management of intraductal papillary mucinous tumors of the pancreas: the role of routine frozen section of the surgical margin, intraoperative endoscopic staged biopsies of the Wirsung duct, and pancreaticogastric anastomosis.

Authors:  J F Gigot; P Deprez; C Sempoux; C Descamps; S Metairie; D Glineur; P Gianello
Journal:  Arch Surg       Date:  2001-11

3.  Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas.

Authors:  Massimo Raimondo; Issei Tachibana; Raul Urrutia; Lawrence J Burgart; Eugene P DiMagno
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

4.  MR cholangiopancreatographic differentiation of benign and malignant intraductal mucin-producing tumors of the pancreas.

Authors:  H Irie; H Honda; H Aibe; T Kuroiwa; K Yoshimitsu; K Shinozaki; K Yamaguchi; M Shimada; K Masuda
Journal:  AJR Am J Roentgenol       Date:  2000-05       Impact factor: 3.959

5.  Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Toshifumi Matsumoto; Masanori Aramaki; Kazuhiro Yada; Seitaro Hirano; Yoshihisa Himeno; Kohei Shibata; Katsunori Kawano; Seigo Kitano
Journal:  J Clin Gastroenterol       Date:  2003-03       Impact factor: 3.062

Review 6.  Intraductal papillary mucinous tumors of the pancreas: spectrum of CT and MR findings with pathologic correlation.

Authors:  C Procacci; G Carbognin; C Biasiutti; A Guarise; C Ghirardi; G Schenal
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

7.  Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography.

Authors:  Enrique Lopez Hänninen; Holger Amthauer; Norbert Hosten; Jens Ricke; Michael Böhmig; Jan Langrehr; Rainer Hintze; Peter Neuhaus; Bertram Wiedenmann; Stefan Rosewicz; Roland Felix
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

8.  Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas.

Authors:  Yuichi Kitagawa; Trisha A Unger; Shari Taylor; Richard A Kozarek; L William Traverso
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

9.  Surgical management of intraductal papillary mucinous tumor of the pancreas.

Authors:  Ryuichiro Doi; Koji Fujimoto; Michihiko Wada; Masayuki Imamura
Journal:  Surgery       Date:  2002-07       Impact factor: 3.982

10.  Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT.

Authors:  Hiroshi Ogawa; Shigeki Itoh; Mitsuru Ikeda; Kojiro Suzuki; Shinji Naganawa
Journal:  Radiology       Date:  2008-07-15       Impact factor: 11.105

View more
  6 in total

1.  Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Ivan Pedrosa; Dennis Boparai
Journal:  World J Gastrointest Surg       Date:  2010-10-27

Review 2.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

Review 3.  Imaging Features for Predicting High-Grade Dysplasia or Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review and Meta-Analysis.

Authors:  Wenjing Zhao; Shanglong Liu; Lin Cong; Yupei Zhao
Journal:  Ann Surg Oncol       Date:  2021-09-23       Impact factor: 5.344

4.  What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses.

Authors:  Asma Sultana; Richard Jackson; Gilbert Tim; Emma Bostock; Eftychia E Psarelli; Trevor F Cox; Robert Sutton; Paula Ghaneh; Michael G T Raraty; John P Neoptolemos; Christopher M Halloran
Journal:  Clin Transl Gastroenterol       Date:  2015-12-10       Impact factor: 4.488

5.  Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis.

Authors:  Shaobo Cao; Ya Hu; Xiang Gao; Quan Liao; Yupei Zhao
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

Review 6.  Pancreatic intraductal papillary mucinous neoplasms: Current diagnosis and management.

Authors:  Beata Jabłońska; Paweł Szmigiel; Sławomir Mrowiec
Journal:  World J Gastrointest Oncol       Date:  2021-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.